ULTA$546.78

Ulta Beauty shows solid but moderating growth: revenue rose from $8.63B to $12.39B over FY2022-FY2026, with TTM at $12.96B, while net income peaked at $1.29B in FY2024 before easing to $1.15B and then $1.21B TTM. Gross margin has stayed fairly stable around 43%, but operating margin has compressed steadily from 16.05% to 12.37%, showing that expense growth is outpacing sales. Earnings look mostly durable, with no major unusual tax or interest distortions; the main issue is structural margin pressure. Versus typical specialty retail, Ulta still screens above average on profitability and cash generation, but the trend is softer. Key risks are rising SG&A, declining margin leverage, and growth that is improving only modestly.

Ulta Beauty’s balance sheet remains workable, but liquidity has tightened noticeably. Total current assets are $3.14B versus total current liabilities of $2.28B, leaving working capital of $787M, down from $1.25B in FY2025. Cash and short-term investments fell to $213M from $703M, while inventory climbed to $2.41B, which ties up a large share of current assets. On the solvency side, total liabilities increased to $4.32B and total debt rose to $2.52B, outpacing equity growth. Shareholders’ equity is still healthy at $2.64B, but the recent debt increase, higher lease obligations, and jump in goodwill/intangibles suggest a more leveraged, less liquid structure than in prior years.

Ulta Beauty shows solid cash generation with operating cash flow generally in the $1.34B-$1.50B range in the last four fiscal years and rising to $1.57B TTM, above FY2025’s $1.50B. Free cash flow has stayed healthy at roughly $964M-$1.17B, with $1.15B TTM despite elevated capital spending of $418M, suggesting reinvestment is being funded comfortably. Cash flow quality is reasonable, though working capital swings remain material, especially inventory and other operating assets. Capital allocation is shareholder-focused: share repurchases were large at $915M in FY2025 and $1.23B TTM, while debt activity spiked in FY2026. Overall, cash generation is stable and strong for a retail business, with manageable volatility.

Ulta Beauty shows a mixed operating profile. Liquidity has weakened notably, with the current ratio slipping from 1.71 to 1.35 and the quick ratio falling from 0.59 to 0.20, indicating less short-term cushion than in prior years. Leverage remains manageable overall, with debt-to-equity near 1.0 and debt-to-EBITDA around 1.0, though net debt metrics have edged higher recently. Efficiency is softer, as asset turnover has eased from 2.02 to 1.91 and inventory turnover has declined from 3.73 to 3.06. Profitability is still strong, but returns have trended down: ROE, ROA, ROIC, and ROCE are all below earlier peaks, though still solid.

Ulta Beauty’s growth profile shows a clear slowdown from the sharp FY2022–FY2023 expansion into a more mature phase in FY2024–FY2025, followed by a re-acceleration in the analyst outlook for FY2026–FY2028. Revenue rises from $8.63B to $11.21B historically, then is projected to rebuild from $11.30B to $13.96B, with growth improving again after the FY2025 pause. EPS has generally grown faster than revenue, suggesting margin expansion, though FY2025 shows a brief decline before a forecast rebound among the estimate years. Sentiment is constructive: the consensus is Buy, targets range from $450 to $731, and coverage from 28 analysts supports confidence. The recommendation mix has also improved modestly, with more Strong Buy ratings and fewer Holds over time.